期刊
ACTA CLINICA BELGICA
卷 77, 期 1, 页码 113-117出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17843286.2020.1780390
关键词
COVID-19; SARS-CoV-2; type 1 diabetes mellitus; SGLT2i; euglycaemic diabetic ketoacidosis; euDKA
Recent publications have shown that individuals with diabetes are at higher risk of developing severe and/or fatal illnesses from COVID-19. This case report highlights the importance of adjusting glucose-lowering drugs in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.
Objective Recent publications on Coronavirus Disease-2019 (COVID-19) report that diabetic people with or without co-morbidities are at higher risk of developing severe and/or fatal illnesses. Method and Result We report the first case of a 60-year-old man with a 27-year history of type 1 diabetes mellitus, infected by SARS-CoV-2 presenting with an euglycaemic ketoacidosis and an acute respiratory distress syndrome Conclusion This case report reminds us of the importance of adjusting more recent glucose-lowering drugs, including sodium-glucose cotransporter 2 inhibitors, in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据